Differences between revisions 13 and 14
Revision 13 as of 2008-07-19 17:17:55
Size: 2047
Editor: cosiapat1
Comment:
Revision 14 as of 2009-02-12 01:03:27
Size: 2051
Editor: localhost
Comment: converted to 1.6 markup
Deletions are marked like this. Additions are marked like this.
Line 6: Line 6:
 * Place: CCBR Black Room ([http://www.cytoscape.org/cgi-bin/moin.cgi/CytoscapeRetreat2008 General location information])  * Place: CCBR Black Room ([[http://www.cytoscape.org/cgi-bin/moin.cgi/CytoscapeRetreat2008|General location information]])
Line 9: Line 9:
This is a private meeting of the Cytoscape board of directors and scientific advisory board members to discuss Cytoscape strategy, funding and scientific directions, as part of the [http://www.cytoscape.org/cgi-bin/moin.cgi/CytoscapeRetreat2008 Cytoscape retreat]. This is a private meeting of the Cytoscape board of directors and scientific advisory board members to discuss Cytoscape strategy, funding and scientific directions, as part of the [[http://www.cytoscape.org/cgi-bin/moin.cgi/CytoscapeRetreat2008|Cytoscape retreat]].

Cytoscape Board Meeting

Description

This is a private meeting of the Cytoscape board of directors and scientific advisory board members to discuss Cytoscape strategy, funding and scientific directions, as part of the Cytoscape retreat.

Attendees

  • Trey Ideker (University of California, San Diego)
  • Gary Bader (University of Toronto)
  • Annette Adler (Agilent Technologies, San Francisco Bay area)
  • Allan Kuchinsky (Agilent Technologies, San Francisco Bay area)
  • Alex Pico (in lieu of Bruce Conklin) (Gladstone Institute of Cardiovascular Disease, UCSF, San Francisco)
  • Benno Schwikowski (Institut Pasteur, Paris)
  • Chris Sander (Memorial Sloan-Kettering Cancer Center, New York)
  • Charlie Boone (University of Toronto)
  • Mark Gerstein (Yale University)
  • Shoshana Wodak (Hospital for Sick Children, Toronto)
  • Yeyejide Adeleye (Unilever, UK)
  • David States (University of Michigan)

Agenda

  • Cytoscape Status Update (Mike Smoot, Cytoscape Chief Architect)
  • Matters arising from the Cytoscape Retreat
    • New secretary/treasurer (Trey)
    • Cytoscape book - what's the goal? (Gary)
    • More face to face core developer meetings - 3/year on west coast? (Gary)
    • More open core development mailing list? (Gary)
  • Outreach (Gary)
  • Funding (Trey)
  • Scientific directions. Goal: create a scientific vision for Cytoscape

Notes

CytoscapeRetreat2008/BoardMeeting (last edited 2009-02-12 01:03:27 by localhost)

Funding for Cytoscape is provided by a federal grant from the U.S. National Institute of General Medical Sciences (NIGMS) of the Na tional Institutes of Health (NIH) under award number GM070743-01. Corporate funding is provided through a contract from Unilever PLC.

MoinMoin Appliance - Powered by TurnKey Linux